Susquehanna International Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$903K Sell
156,416
-15,032
-9% -$86.7K ﹤0.01% 3420
2025
Q1
$1.13M Buy
171,448
+86,934
+103% +$574K ﹤0.01% 3141
2024
Q4
$736K Buy
84,514
+60,193
+247% +$524K ﹤0.01% 3453
2024
Q3
$475K Sell
24,321
-19,538
-45% -$382K ﹤0.01% 3723
2024
Q2
$903K Sell
43,859
-551,020
-93% -$11.3M ﹤0.01% 2701
2024
Q1
$12.7M Buy
594,879
+530,196
+820% +$11.3M ﹤0.01% 535
2023
Q4
$930K Sell
64,683
-26,681
-29% -$384K ﹤0.01% 2968
2023
Q3
$833K Sell
91,364
-3,315
-4% -$30.2K ﹤0.01% 2796
2023
Q2
$1M Sell
94,679
-15,266
-14% -$162K ﹤0.01% 2721
2023
Q1
$1.34M Buy
109,945
+48,913
+80% +$598K ﹤0.01% 2480
2022
Q4
$757K Sell
61,032
-47,338
-44% -$587K ﹤0.01% 2647
2022
Q3
$1.48M Buy
+108,370
New +$1.48M ﹤0.01% 2016
2022
Q2
Sell
-61,529
Closed -$989K 6287
2022
Q1
$989K Sell
61,529
-118,432
-66% -$1.9M ﹤0.01% 2828
2021
Q4
$2.52M Buy
179,961
+105,886
+143% +$1.48M ﹤0.01% 1729
2021
Q3
$1.39M Buy
74,075
+33,975
+85% +$636K ﹤0.01% 2366
2021
Q2
$836K Buy
40,100
+25,005
+166% +$521K ﹤0.01% 3221
2021
Q1
$427K Sell
15,095
-128,658
-89% -$3.64M ﹤0.01% 4007
2020
Q4
$4.7M Sell
143,753
-112,791
-44% -$3.68M ﹤0.01% 1032
2020
Q3
$7.86M Buy
256,544
+187,986
+274% +$5.76M ﹤0.01% 641
2020
Q2
$1.12M Buy
68,558
+46,544
+211% +$758K ﹤0.01% 2025
2020
Q1
$219K Buy
+22,014
New +$219K ﹤0.01% 3709
2019
Q4
Sell
-18,697
Closed -$284K 4444
2019
Q3
$284K Sell
18,697
-8,359
-31% -$127K ﹤0.01% 3468
2019
Q2
$533K Buy
+27,056
New +$533K ﹤0.01% 2843
2019
Q1
Hold
0
3845
2018
Q4
Hold
0
4309
2018
Q3
Hold
0
4065
2018
Q2
Hold
0
4188
2017
Q2
Sell
-14,156
Closed -$125K 3968
2017
Q1
$125K Buy
+14,156
New +$125K ﹤0.01% 2945